Inventurus Knowledge Solutions Ltd. IPO
Inventurus Knowledge Solutions Limited (IKS Health), a leading healthcare technology solutions provider, announces its Initial Public Offering from December 12 to December 16, 2024.
This article provides a detailed overview of the IPO, including key details, financials, important dates and issue review for market enthusiasts.
This article provides a detailed overview of the IPO, including key details, financials, important dates and issue review for market enthusiasts.
R5
by RA ALOK DAIYA SEBI Reg. INH000011468, BSE Enlistment No. 5737
About Inventurus Knowledge Solutions Limited
Inventurus Knowledge Solutions Limited, also known as IKS Health, is a healthcare technology company founded in 2006, providing comprehensive services to healthcare enterprises that enable providers to focus more on patient care.
Global Healthcare Technology Leader
Operating across India, United States, and Philippines, IKS Health serves over 30,000 healthcare providers worldwide through its comprehensive technology platform for both outpatient and inpatient care facilities.
Advanced Technology Infrastructure
The company's cutting-edge infrastructure combines artificial intelligence, machine learning, and robotic process automation to revolutionize healthcare operations and enhance medical practice efficiency.
Proven Healthcare Impact
IKS Health has achieved remarkable results, reducing administrative burden by 70% while processing over 35 million medical records annually and significantly improving patient satisfaction rates.
Growing Professional Network
With a team of over 14,000 professionals and numerous industry accolades, including recognition from KLAS Research, IKS Health continues to lead innovation in healthcare technology solutions.
Key Services:
- Clinical support
- Medical documentation management
- Virtual medical scribing
Company Reach:
- Serves over 778 healthcare organizations
- Team of over 13,528 employees, including 2,612 clinically-trained professionals
- Operates in the US, Canada, and Australia
IPO Details and Structure
Issue Size
18,795,510 equity shares (Offer for Sale)
Face Value
₹1 per equity share
Price Band
₹1265 to ₹1329 per equity share
Lot Size
11 shares
Issue Type
Book Built Issue IPO
Listing At
BSE, NSE
IPO Timeline
1
December 12, 2024
IPO Opening Date - Start of public subscription period
2
December 16, 2024
IPO Closing Date and UPI Mandate Confirmation (by 5 PM)
3
December 17, 2024
Basis of Allotment Announcement
4
December 18, 2024
Initiation of Refunds and Credit of Shares to Demat Accounts
5
December 19, 2024
Listing Date - Shares begin trading on BSE and NSE
IPO Reservation and Lot Size
Reservation of Shares:
Lot Size and Investment:
Minimum Lot Size
11 shares (₹14,619 for retail investors)
Maximum Retail Application
13 lots (143 shares, ₹190,047)
Minimum S-HNI Application
14 lots (154 shares, ₹204,666)
Minimum B-HNI Application
69 lots (759 shares, ₹1,008,711)
Financial Information and Key Performance Indicators
Financial Highlights (Restated Consolidated):
Key Performance Indicators (as of March 31, 2024):
Return on Equity (ROE)
32%
Return on Capital Employed (ROCE)
31.56%
Debt to Equity Ratio
-0.06
Price to Book Value (P/BV)
19.07
PAT Margin
20.38%
IPO Lead Managers
Book Running Lead Managers:
- ICICI Securities Limited
- Jefferies India Private Limited
- JM Financial Limited
- J.P. Morgan India Private Limited
- Nomura Financial Advisory And Securities (India) Pvt Ltd
IPO Review
The company demonstrates strong client retention, with over 98 per cent of revenue derived from repeat customers, underpinned by its ‘land and expand’ strategy. The US healthcare market's growth trajectory, combined with increasing reliance on outsourced services, offers significant expansion potential for IKS.
Furthermore, the company’s strong fundamentals, scalable solutions, asset-light model and alignment with evolving healthcare needs position it as a sustainable investment.
Furthermore, the company’s strong fundamentals, scalable solutions, asset-light model and alignment with evolving healthcare needs position it as a sustainable investment.